The pharmaceutical and agrochemical industries depend on a wide range of suppliers for active ingredients, specialty chemicals, intermediates, formulation ingredients, crop-protection chemicals, biologicals, and other advanced materials.
Some companies focus mainly on one industry, while others have diversified portfolios serving both healthcare and agriculture. Among the major names, BASF, Bayer, Evonik, Merck KGaA, Syngenta Group, Corteva Agriscience, and UPL stand out because of their scale, manufacturing networks, R&D capabilities, and product portfolios.
BASF: A Major Supplier Across Chemicals and Agriculture
BASF is one of the clearest examples of a company supplying both pharmaceutical-related and agrochemical value chains. Its portfolio spans chemicals, nutrition and care, specialty materials, and agricultural solutions.
In 2025, BASF generated €59.7 billion in total sales, while its Agricultural Solutions business generated €9.59 billion. The segment included fungicides, herbicides, insecticides, seed treatment, and seeds & traits.
BASF also invested €990 million in R&D within Agricultural Solutions in 2025, showing how heavily the business depends on product innovation.
| BASF – 2025 | Data |
|---|---|
| Total BASF sales | €59.7B |
| Agricultural Solutions sales | €9.59B |
| Agricultural Solutions EBITDA before special items | €2.08B |
| Agricultural Solutions R&D | €990M |
Bayer: Healthcare and Crop Science Under One Company
Bayer has an unusually broad position because it operates major businesses in both Pharmaceuticals and Crop Science.
In 2025, Bayer reported €45.6 billion in total sales. Pharmaceuticals generated €17.83 billion, while Crop Science generated €21.62 billion.
Within Crop Science, 2025 sales included €7.15 billion from Corn Seed & Traits, €5.28 billion from herbicides, €2.89 billion from fungicides, and €1.37 billion from insecticides.
| Bayer – 2025 | Data |
|---|---|
| Total sales | €45.58B |
| Pharmaceuticals sales | €17.83B |
| Crop Science sales | €21.62B |
| Employees | 89,237 |
Bayer’s scale makes it particularly relevant when looking for a supplier with expertise spanning both life sciences and agricultural inputs.
Evonik: Specialty Chemicals for Life Sciences
Evonik is another important supplier, particularly in specialty chemicals, pharmaceutical ingredients, formulation technologies, and nutrition-related applications.
The company generated €14.1 billion in sales in 2025 and reported adjusted EBITDA of €1.87 billion. Its Care Solutions business generated €3.68 billion in 2025, while Health Care was highlighted as an important contributor to earnings growth.
| Evonik – 2025 | Data |
|---|---|
| Total sales | €14.1B |
| Adjusted EBITDA | €1.87B |
| Care Solutions sales | €3.68B |
| Key strength | Specialty chemicals & life sciences |
For pharmaceutical manufacturers, Evonik’s importance comes from its specialty-chemical expertise rather than simply its overall company size.
Merck KGaA: Strong Life Science and Pharmaceutical Supply
Merck KGaA is another major supplier to the pharmaceutical ecosystem, particularly through its Life Science business.
In 2025, Merck’s Life Science sales reached €8.98 billion, representing 42% of group sales, while Healthcare generated €8.61 billion. The company also had approximately €4 billion in orders received at the end of 2025 that were expected to generate future sales, with around €3 billion related to Life Science.
| Merck KGaA – 2025 | Data |
|---|---|
| Life Science sales | €8.98B |
| Healthcare sales | €8.61B |
| Life Science share of group sales | 42% |
| Future order book | ~€4B |
This makes Merck particularly relevant for pharmaceutical companies requiring laboratory, bioprocessing, analytical, and production-related solutions.
Syngenta Group: One of the Largest Agrochemical Suppliers
When the focus shifts toward agricultural chemicals, Syngenta Group is one of the largest names globally.
Syngenta reported $28.4 billion in 2025 sales, with $13.7 billion from Crop Protection and $4.8 billion from Seeds. Its Crop Protection business also secured more than 1,800 approvals during 2025.
| Syngenta Group – 2025 | Data |
|---|---|
| Group sales | $28.4B |
| Crop Protection sales | $13.7B |
| Seeds sales | $4.8B |
| Crop Protection approvals | 1,800+ |
Its portfolio includes herbicides, fungicides, insecticides, biologicals, seed treatments, and seeds.
Corteva Agriscience: Seeds and Crop Protection
Corteva is another major agricultural-input supplier, with operations concentrated around Seeds and Crop Protection.
The company generated $17.4 billion in 2025 net sales, including $9.90 billion from Seed and $7.50 billion from Crop Protection. Corteva also reported approximately 22,000 employees, 120 R&D sites, and 95 production and manufacturing sites, with sales in about 110 countries.
| Corteva – 2025 | Data |
|---|---|
| Net sales | $17.4B |
| Seed sales | $9.90B |
| Crop Protection sales | $7.50B |
| R&D sites | 120 |
| Manufacturing sites | 95 |
| Employees | 22,000 |
UPL: A Large Global Crop-Protection Supplier
UPL is another major supplier, particularly across crop protection, seeds, post-harvest solutions, and specialty chemistries.
Its FY2025–26 annual report shows revenue of ₹51,839 crore, EBITDA of ₹9,588 crore, and an EBITDA margin of 18.5%. Its net worth reached ₹34,696 crore, while cash from operations was ₹7,855 crore.
| UPL – FY2025–26 | Data |
|---|---|
| Revenue | ₹51,839 crore |
| EBITDA | ₹9,588 crore |
| EBITDA margin | 18.5% |
| Net worth | ₹34,696 crore |
| Cash from operations | ₹7,855 crore |
What Do These Supplier Data Tell Us?
The supplier landscape is highly diversified. BASF and Bayer have significant exposure to both agriculture and broader life sciences, while Evonik and Merck KGaA are particularly important across specialty chemicals and pharmaceutical supply chains.
On the agricultural side, Syngenta, Corteva, and UPL have substantial scale in crop protection, seeds, biologicals, and related technologies.
Importantly, scale is only one factor when selecting a supplier. Pharmaceutical and agrochemical manufacturers also need to evaluate GMP and regulatory compliance, manufacturing capacity, raw-material security, quality systems, geographic footprint, supply reliability, technical support, and R&D capabilities.
Overall, these companies illustrate how modern pharmaceutical and agrochemical supply chains increasingly depend on large, technically specialized suppliers capable of supporting products from R&D and intermediates through formulation, manufacturing, and global commercial supply.
Important Links
Get a customized and personalized pharma dashboard built around your niche; with the exact data and insights you need. Request for a demo: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium